a public good project by the
Synthesis
Company
of California

© 2026

Pierre Perraut | doi.page

0 works0 citations0 h-index

Google Scholar OpenAlex

Pierre Perraut

Sanofi (France)(FR)

Research Areas

Cellular transport and secretion, PI3K/AKT/mTOR signaling in cancer, Biochemical and Molecular Research

Most-Cited Works

→ Discovery of (2S)-8-[(3R)-3-Methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido[1,2-a]pyrimidin-6-one: A Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors(2014)90 cited